Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva
Guided Therapeutics Inc (GTHP)
NASDAQ:AMEX Investor Relations:
guidedinc.com/investors
Company Research
Source: Business Wire
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, announced today that preliminary findings from its FDA pivotal clinical trial demonstrate that there is a strong clinical need for LuViva's ability to detect cases of cervical precancer and cancer currently missed by the standard of care. Specifically, the study’s preliminary results show that current practice fails to detect a substantial percentage of early cervical precancers for women referred to biopsy based on abnormal Pap and/or HPV results.According to Mark Faupel, CEO of Guided Therapeutics, “Previous studies have shown that the current practice consisting of biopsies based on colposcopy (a magnified view of the cervix after application of acetic acid) can miss significant disease 20 to 40 percent of the time. In our study, the prim
Show less
Read more
Impact Snapshot
Event Time:
GTHP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GTHP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GTHP alerts
High impacting Guided Therapeutics Inc news events
Weekly update
A roundup of the hottest topics
GTHP
News
- Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva [Yahoo! Finance]Yahoo! Finance
- Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor [Yahoo! Finance]Yahoo! Finance
- Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese DistributorBusiness Wire
- Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments CorporationBusiness Wire